Thursday February 23, 2017 00:20
Food and Healthcare Press Releases
At the University Hospital Basel all patient information is stored digitally in the hospital's data center. It is essential that the facility's electrical infrastructure is the best that it can be – lives depend on it. The hospital decided to
60 years after the market launch of Contergan (active ingredient: thalidomide), the greatest pharmaceutical scandal in the Federal Republic of Germany continues to boil. A lawsuit will be heard in the Bonn Regional Court at 12:00 hrs on 15.2.2017 that is more explosive than appears at first sight.
The Contergan victim Andreas Meyer, who was born without arms or legs and is confined to a wheelchair, is suing the former member of the Management Board of the Contergan Foundation, Attorney Karl Schucht, for injunction and rectification.
In a letter to the members of the Family Affairs Committee of the German Federal Parliament, Schucht had asserted that Meyer, as an expert witness at a public hearing of the Committee, had publicly stated various untruths about events connected with the Contergan Foundation.
Meyer had said among other things that for 30 years the Contergan (thalidomide) manufacturer Grunenthal GmbH had had access to the medical files of the Contergan victims in the Contergan Foundation. In addition, Grunenthal had also paid the Foundation's medical experts.
- First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression Janssen Sciences Ireland UC
Baricitinib, marketed as Olumiant, is the first JAK inhibitor approved to treat RA in the EU Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the European Commission has granted marketing authorisation for
Patient preference data presented today at the 10th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) demonstrated the importance of flexible storage on daily use of FVIII treatments in people with haemophilia A.
- Merck is broadening its efforts to support ART clinics to achieve excellence for patients - Through leading edge education and training, the Centre of Excellence aims to support clinics to achieve consistent and high level of outcome Merck, a leading
Ceva Sante Animale today completed the acquisition of a diversified portfolio of products, including swine and cattle vaccines and multi-species nonsteroidal anti-inflammatories from Boehringer Ingelheim following its acquisition of Merial Animal
Merck , a leading science and technology company, today announced the opening of a facility in Mollet des Valles, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast
Australian fertility group Genea and German science and technology company Merck have today opened The Centre of Excellence for Fertility in Bangkok. The Centre of Excellence for Fertility has been developed with the goal of creating a global benchmark
Launch of Scoreflex(TM) NC responds to cardiologists' need for a non-compliant scoring balloon in more resistant lesions OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has launched the Scoreflex NC, a
- Biodevelopment centers in Boston, Mass. and Shanghai, China feature full suite of Merck technologies and services - New process development centers and full single-use GMP facility in France to accelerate development of biologics Merck , a leading
Sun Pharma announced successful Phase 3 confirmatory clinical trial results for Seciera(TM) (cyclosporine A, 0.09% ophthalmic solution), for the treatment of dry eye disease. Seciera(TM) is a patented, novel, proprietary nanomicellar formulation of
New Year is right around the corner! Ring in 2017 with confidence and discover the upcoming beauty trends from the insiders with Romrawin, premium beauty center and Thailand's leading aesthetic clinic, who will share with you what's hot and what's
- Enables Merck to offer its customers complete workflow solutions for food pathogen testing Merck , a leading life science and technology company, today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The
On December 20th, 2016, Samitivej Hospital held a press conference on the evolution of dengue prevention in Thailand which has led to the introduction of the first vaccine against four strains of the dengue virus, reducing its severity and allowing a
BioNet's vaccine is the first recombinant monovalent Pertussis vaccine in the world to receive a MAA for booster indication in adolescents and adults BioNet-Asia announced today that its first recombinant acellular Pertussis booster vaccine containing a
Use of ImmunoXpert has the potential to improve patient management and reduce drug resistance due to antibiotic overuse ImmunoXpert significantly outperformed routine tests MeMed Ltd. announced today Lancet Infectious Diseases' publication of the
Mr. Ronald Lavater (5th from right), Bumrungrad's Corporate CEO, recently led the project's physicians and nursing team to receive the 4th award from H.E. Glyn Townsend Davies, the U.S. Ambassador to Thailand (5th from left). The award was granted by the
BOTHELL, Washington and COPENHAGEN, Denmark and BERKELEY, California and TOKYO--20 Dec--PRNewswire/InfoQuest CMC Biologics to continue to provide CDMO services to the biopharma marketplace CMC Biologics, a global leader in clinical and commercial
AGC Asahi Glass ("AGC"), a world-leading manufacturer of glass, chemicals and high-tech materials, announced on December 20 that it has entered into an agreement to acquire 100% of the shares in CMC Biologics ("CMC"), a world-leading biologics active
Oxford Gene Technology[ http://www.ogt.com ] (OGT), The Molecular Genetics Company, has expanded its range of Cytocell Aquarius(R) fluorescence in situ hybridisation (FISH) probes for pathology. OGT has introduced three new probes: FUS Breakapart and
เมื่อวันจันทร์ที่ 12 ธันวาคมที่ผ่านมา ณ ห้องบอลรูม USC Town and Gown คุณพินชาส โคเฮน คณบดีประจำ USC Leonard Davis School of Gerontology ได้ประกาศสถาปนาตำแหน่ง Kevin Xu Chair in Gerontology รวมถึงประกาศคุณงามความดีของ Rongxiang Xu Regenerative Life
At USC Town and Gown on Monday, December 12, USC Leonard Davis School of Gerontology Dean Pinchas Cohen announced the installation of Kevin Xu Chair in Gerontology and the dedication of Rongxiang Xu Regenerative Life Science Lab, made possible with
Last week, three EU institutions (the European Parliament, the European Commission and the Council of the European Union) reached a provisional agreement to ban dental amalgam fillings for children under 15 and pregnant and breastfeeding women as of July